Dr Lal Path Labs Q4 Results: Co beats quarterly profit view on medical testing boom

April 25, 2025

Dr Lal Path Labs, India’s largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its bundled test packages lifted growth amid rising health awareness in the country.

More To Explore

Railways PSU ETF delivers 16% in a week. Is this the right opportunity for portfolio diversification?

A railways PSU-focused ETF delivered a sharp 16% gain in just one week, as per ETMutualFunds analysis. The Groww Nifty India Railways PSU ETF rose

May 19, 2025

IPO market starts buzzing; 6 companies line up plans to raise over Rs 11,000-cr in May

After a tepid start to 2025, the IPO market is getting back on track with six main-board companies, including Schloss Bangalore — owner of luxury

May 19, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003